These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 5050051

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Effects of long-acting fluphenazine].
    Marcjan K, Pietruszewska I, Wolak E.
    Psychiatr Pol; 1973; 7(1):79-86. PubMed ID: 4715837
    [No Abstract] [Full Text] [Related]

  • 43. [Flufenazine decanoate in the ambulatory treatment of schizophrenic patients].
    Populin M, De Vanna M, Poldrugo F.
    Minerva Psichiatr; 1981; 22(2):85-92. PubMed ID: 7022095
    [No Abstract] [Full Text] [Related]

  • 44. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW.
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J.
    Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
    [No Abstract] [Full Text] [Related]

  • 48. [Remarks on the action of Moditen-retard and Modecate. Apropos of 65 cases].
    Scherrer P, Quiniou-Vidalenc.
    Ann Med Psychol (Paris); 1976 Nov; 2(4):642-56. PubMed ID: 1020862
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
    Bohacek N, Mihovilović M.
    Neuropsihijatrija; 1968 Nov; 16(3):69-73. PubMed ID: 5195835
    [No Abstract] [Full Text] [Related]

  • 53. [Depot fluphenazine as a means of stabilizing remission in cases of schizophrenia].
    Vovin RIa, Vovina EN.
    Psychiatr Neurol Med Psychol Beih; 1975 Nov; 20-21():183-7. PubMed ID: 829620
    [Abstract] [Full Text] [Related]

  • 54. [Therapeutic trial with a long-acting phenothiazine derivative. Fluphenazine enanthate in a group of chronic schizophrenics].
    Mariátegui J, Alarcón R, Arana J, Azcárate C, Butler A.
    Rev Neuropsiquiatr; 1966 Mar; 29(1):33-44. PubMed ID: 5940303
    [No Abstract] [Full Text] [Related]

  • 55. Fluphenazine: twelve years' experience.
    Ayd FJ.
    Dis Nerv Syst; 1968 Nov; 29(11):744-7. PubMed ID: 5752634
    [No Abstract] [Full Text] [Related]

  • 56. [3 years' experience with depot fluphenazine].
    Horn HJ.
    Med Klin; 1969 Nov 28; 64(48):2247-51. PubMed ID: 5359270
    [No Abstract] [Full Text] [Related]

  • 57. Drug monitoring at an Australia depot phenothiazine clinic.
    Marriott P, Hiep A.
    J Clin Psychiatry; 1978 Mar 28; 39(3):206-12. PubMed ID: 580271
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.